secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartSciences Inc. (HSCS)
CIK:        0001468492
Form:       8-K
Filed at:   2025-08-04T23:59:59+00:00
Accession:  0001213900-25-070889
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HeartSciences increases ATM equity offering limit to $25M in amended distribution agreement
--------------------------------------------------------------------------------

- Amendment No. 3 to Equity Distribution Agreement raises maximum offering from $15M to $25M of common stock.
- Commission rate: 4% on gross proceeds up to $11,036,310; 3% on excess.
- Non-affiliate public float ~$14.7M; shelf sales limited to ~$4.9M per 12 months under S-3 I.B.6.
- No shares sold under I.B.6 in prior 12 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468492/000121390025070889/0001213900-25-070889-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468492/000121390025070889/ea0251488-8k_heart.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-070889

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer